Sunrest Lifescience Limited (NSE:SUNREST)
India · Delayed Price · Currency is INR 33.00
+2.50 (8.20%)
Jan 23, 2026, 1:05 PM IST
Sunrest Lifescience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| 520.34 | 334.13 | 294.83 | 246.42 | 268.88 | 169.49 | Upgrade | |
Revenue Growth (YoY) | 60.61% | 13.33% | 19.65% | -8.35% | 58.64% | 54.76% | Upgrade |
Cost of Revenue | 333.07 | 200.78 | 199.88 | 148.78 | 174.62 | 113.6 | Upgrade |
Gross Profit | 187.28 | 133.36 | 94.95 | 97.65 | 94.25 | 55.89 | Upgrade |
Selling, General & Admin | 60.56 | 50.07 | 39.69 | 33.28 | 26.62 | 24.87 | Upgrade |
Other Operating Expenses | 81.02 | 53.05 | 46.18 | 35.03 | 56.52 | 28.27 | Upgrade |
Operating Expenses | 149.24 | 104.08 | 86.84 | 69.61 | 83.74 | 53.57 | Upgrade |
Operating Income | 38.04 | 29.28 | 8.11 | 28.03 | 10.51 | 2.32 | Upgrade |
Interest Expense | -8.91 | -2.89 | -0.65 | -0.59 | -0.23 | -0.08 | Upgrade |
Interest & Investment Income | 0.01 | 0.01 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0.17 | -0.17 | -1.53 | -0 | - | -0 | Upgrade |
EBT Excluding Unusual Items | 28.98 | 26.23 | 5.93 | 27.44 | 10.28 | 2.24 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.22 | - | Upgrade |
Pretax Income | 28.98 | 26.23 | 5.93 | 27.44 | 10.5 | 2.24 | Upgrade |
Income Tax Expense | 8.15 | 6.13 | 3.67 | 7.01 | 2.73 | 0.58 | Upgrade |
Earnings From Continuing Operations | 20.83 | 20.11 | 2.26 | 20.43 | 7.77 | 1.66 | Upgrade |
Minority Interest in Earnings | -3.22 | -0.05 | - | - | - | - | Upgrade |
Net Income | 17.6 | 20.05 | 2.26 | 20.43 | 7.77 | 1.66 | Upgrade |
Net Income to Common | 17.6 | 20.05 | 2.26 | 20.43 | 7.77 | 1.66 | Upgrade |
Net Income Growth | - | 788.48% | -88.95% | 162.91% | 369.55% | 349.73% | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 3 | 3 | 3 | 3 | Upgrade |
Shares Change (YoY) | - | 29.14% | 10.77% | - | - | - | Upgrade |
EPS (Basic) | 4.10 | 4.67 | 0.68 | 6.81 | 2.59 | 0.55 | Upgrade |
EPS (Diluted) | 4.10 | 4.67 | 0.68 | 6.81 | 2.59 | 0.55 | Upgrade |
EPS Growth | - | 587.57% | -90.03% | 162.93% | 370.91% | 348.37% | Upgrade |
Free Cash Flow | -27.3 | 15.49 | -148.05 | 11.41 | -9.15 | -0.09 | Upgrade |
Free Cash Flow Per Share | -6.36 | 3.61 | -44.55 | 3.80 | -3.05 | -0.03 | Upgrade |
Gross Margin | 35.99% | 39.91% | 32.20% | 39.63% | 35.05% | 32.98% | Upgrade |
Operating Margin | 7.31% | 8.76% | 2.75% | 11.38% | 3.91% | 1.37% | Upgrade |
Profit Margin | 3.38% | 6.00% | 0.77% | 8.29% | 2.89% | 0.98% | Upgrade |
Free Cash Flow Margin | -5.25% | 4.64% | -50.21% | 4.63% | -3.40% | -0.05% | Upgrade |
EBITDA | 45.69 | 30.23 | 9.09 | 29.33 | 11.11 | 2.75 | Upgrade |
EBITDA Margin | 8.78% | 9.05% | 3.08% | 11.90% | 4.13% | 1.62% | Upgrade |
D&A For EBITDA | 7.65 | 0.95 | 0.97 | 1.3 | 0.6 | 0.43 | Upgrade |
EBIT | 38.04 | 29.28 | 8.11 | 28.03 | 10.51 | 2.32 | Upgrade |
EBIT Margin | 7.31% | 8.76% | 2.75% | 11.38% | 3.91% | 1.37% | Upgrade |
Effective Tax Rate | 28.13% | 23.35% | 61.92% | 25.54% | 26.01% | 26.02% | Upgrade |
Revenue as Reported | 520.39 | 334.18 | 294.84 | 246.71 | 269.1 | 169.49 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.